PANGEM

Trademark usage description

prognostic ihc (immunochemistry) test in the field of cancer for medical diagnostic uses; pharmaceutical products, namely, gemcitabine response will b Read More

Classification Information

Class [005]
Prognostic IHC (Immunochemistry) test in the field of cancer for medical diagnostic uses; pharmaceutical products, namely, gemcitabine response will be directly and indirectly influenced by the presence of hENT1 (protein) in the tumor which can be detected by 10D7G2 monoclonal antibody maker and its regulation; Prognostic lab test for medical laboratory use; Diagnostic preparations for medical purposes in the field of cancer.

Classification kind code

Class [042]
Computer and scientific

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [044]
Development of laboratory medical prognostic IHC test kits for others; Medical information services, namely, clinical laboratory testing for cancer research purposes for physicians and other medical professionals; Medical information services, namely, clinical laboratory testing for cancer diagnostic or treatment purposes for physicians and other medical professionals

Classification kind code

Mark Details

Serial Number

2064582

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 6^th Sept 2024	Search Recorded
Submitted for opposition 20 on 6^th Sept 2024	Examiner's First Report
Submitted for opposition 287 on 25^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 18^th Nov 2020	Filed
Submitted for opposition 1 on 18^th Nov 2020	Created
Submitted for opposition 31 on 18^th Nov 2020	Formalized

PANGEM

Classification Information

Classification kind code

Class [042]Computer and scientific

Comment text

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Computer and scientific